SCHEMBL5139995

SCHEMBL5139995

COc1cc(C#N)c([N+](=O)[O-])cc1O.COc1cc(C#N)c([N+](=O)[O-])cc1OCCCN1CCN(C)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 9/20 0.46
WEE2 P0C1S8 2/20 0.44
WEE1 P30291 2/20 0.44
PKMYT1 Q99640 2/20 0.44
ALDH1A1 P00352 5/20 0.44
KDM4E B2RXH2 4/20 0.44
TDP1 Q9NUW8 1/20 0.44
FYN P06241 2/20 0.44
ABL1 P00519 2/20 0.44
EGFR P00533 2/20 0.44
SYK P43405 2/20 0.44
CHEK1 O14757 2/20 0.44
STK25 O00506 1/20 0.44
CIT O14578 1/20 0.44
RIOK3 O14730 1/20 0.44
MAP2K7 O14733 1/20 0.44
CASK O14936 1/20 0.44
GAK O14976 1/20 0.44
EPHB6 O15197 1/20 0.44
MAP3K13 O43283 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5025184 0.94 SRC (0.50) SRCWEE2WEE1PKMYT1ALDH1A1
SCHEMBL3280339 0.84 CYP2D6 (0.56) SRCALDH1A1KDM4EFYNABL1
SCHEMBL14421398 0.84 CYP2D6 (0.56) SRCALDH1A1KDM4EFYNABL1
SCHEMBL5027796 0.78 EGFR (0.47) ALDH1A1KDM4ETDP1EGFRSYK
SCHEMBL4087889 0.78 ALDH1A1 (0.51) SRCWEE2WEE1PKMYT1ALDH1A1
SCHEMBL17375521 0.77 SIRT6 (0.51) ALDH1A1KDM4ETDP1EGFRSLC29A1
SCHEMBL5027787 0.77 ABL1 (0.48) SRCALDH1A1ABL1EGFRABL2
SCHEMBL2164504 0.77 MAPT (0.41) ALDH1A1KDM4ETDP1EGFRERBB2
SCHEMBL17922740 0.77 ALDH1A1 (0.42) ALDH1A1KDM4ETDP1CYP2D6L3MBTL1
SCHEMBL2163708 0.77 ALDH1A1 (0.42) ALDH1A1KDM4ETDP1CYP2D6L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1299381-B1 SUBSTITUTED QUINAZOLINE DERIVATIVES AND THEIR USE AS INHIBITORS ASTRAZENECA AB (SE) 2008-05-07 EP disclosed